{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-187328","form_type":"8-K","ticker":"COYA","cik":"0001835022","company_name":"Coya Therapeutics, Inc.","filed_at":"2023-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.593599+00:00","generated_at":"2026-06-13T08:21:29.374929+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Coya Therapeutics appoints Dr. Fred Grossman as President and CMO; compensation terms disclosed","bullets":["Base salary of $450,000/year; annual bonus target of 40% of base salary based on company/individual performance.","Two option grants of 74,069 each (start date and Jan 2024) vesting over 3 years; additional equity possible.","Severance: 9 months base salary plus 9 months accelerated vesting if terminated without cause or resigns for good reason.","Employment effective July 17, 2023; initial term 2 years with auto-renewal."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-187328","json":"https://secwatch.observer/filing/0001193125-23-187328.json","markdown":"https://secwatch.observer/filing/0001193125-23-187328.md","text":"https://secwatch.observer/filing/0001193125-23-187328.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835022/000119312523187328/0001193125-23-187328-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835022/000119312523187328/d499175d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T08:21:29.374929+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2a93bbd7ed","claim":"Dr. Fred Grossman was appointed as President and Chief Medical Officer at Coya Therapeutics, Inc..","evidence_excerpt":"Dr. Fred Grossman, who will assume the role of President and Chief Medical Officer as of July 17, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312523187328/0001193125-23-187328-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}